Source: European Medicines Agency (EU) Revision Year: 2022 Publisher: Gennisium Pharma, Swen Parc de Vitrolles, Chemin de la Bastide Blanche, 13127 Vitrolles France
Gencebok 10 mg/ml solution for infusion.
| Pharmaceutical Form |
|---|
|
Solution for infusion. Clear, colourless, aqueous solution, with a pH of 4.8 and an osmolality of 65 to 95 mOsm/kg. |
Each ml contains 10 mg caffeine citrate (equivalent to 5 mg caffeine).
Each 1 ml ampoule contains 10 mg caffeine citrate (equivalent to 5 mg caffeine).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Caffeine |
Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant. |
| List of Excipients |
|---|
|
Citric acid monohydrate |
Type I clear glass 1 ml ampoule coded by 2 blue rings.
Pack size of 50 ampoules.
Gennisium Pharma, Swen Parc de Vitrolles, Chemin de la Bastide Blanche, 13127 Vitrolles – France
EU/1/20/1465/001
Date of first authorisation: 19 August 2020
| Drug | Countries | |
|---|---|---|
| GENCEBOK | Austria, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
